XE: the cash flow

MyFinsight

For the quarter ending 2026-03-31, XE had -$234,344K decrease in cash & cash equivalents over the period. -$110,219K in free cash flow.

Cash Flow	2026-03-31
Net loss	-166,217
Other depreciation and amortization	451
Unit-based compensation	4,265
Mark-to-market loss (gain) on warrant liabilities	108,899
Mark-to-market loss on c-2 notes	0
Accretion and amortization on investments	1,122
Accounts receivable and unbilled receivables	-5,293
Prepaid and other current assets	7,118
Due from related parties	-399
Operating lease right-of use assets	-2,694
Accounts payable and accrued liabilities	13,621
Long-term deferred revenue	2,892
Accrued interest receivable	653
Other long-term assets	31,201
Due to related parties	72
Operating lease liabilities	473
Net cash used in operating activities	-67,252
Capital expenditures	42,967
Reimbursement of capital expenditures under government grant	28,766
Purchase of investments	189,906
Proceeds from maturities on investments	38,100
Net cash used in investing activities	-166,007
Payments of mezzanine equity issuance costs	0
Payment of debt issuance costs	0
Payment of deferred transaction costs	-1,550
Proceeds from issuance of preferred units	500
Net cash provided by (used in) financing activities	-1,050
Net effect of exchange rate	-35
Net increase (decrease) in cash, cash equivalents, and restricted cash	-234,344
Cash, cash equivalents and restricted cash at beginning of period	462,630
Cash, cash equivalents, and restricted cash at end of period	228,286

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.